Skip to main content
Log in

Post-abortion complications after interruption of pregnancy with misoprostol

  • Published:
Advances in Contraception

Abstract

The high incidence of abortion in Brazil and the increased use of misoprostol among women having clandestine/unsafe abortions has led to an interest in evaluating whether there is an association between the use of misoprostol and the incidence of septic complications post-abortion. To test this association, a retrospective cohort study was conducted with 1840 women treated post-abortion at the Instituto Materno-Infantil de Pernambuco (IMIP) between 1988 and 1992. Incidence of infection (4.2%) was lower in women stating they had used misoprostol than in those stating that the abortion was not induced (7.9%) and twelve times lower than in women stating that they had used other methods (49.4%). These results suggest that misoprostol is a safe, inexpensive method for inducing abortion, and leads to fewer complications and consequently shorter hospital stays. Misoprostol should be considered a viable option in situations where induction of abortion is legal or medically indicated.

Resumé

L'incidence élevée des interruptions de grossesse au Brésil et le recours de plus en plus fréquent au misoprostol par les femmes se soumettant à des avortements clandestins/dangereux ont conduit à rechercher une association éventuelle entre l'utilisation du misoprostol et l'incidence des complications septiques après l'avortement. Pour évaluer cette association, une étude cohorte rétrolective a été menée sur 1840 femmes traitées après l'avortement à l'Instituto Materno-Infantil de Pernambouc entre 1988 et 1992.

L'incidence d'infection (4,2%) était moins élevée chez les femmes ayant signalé qu'elles avaient utilisé le misoprostol que chez celles ayant déclaré que l'avortement n'avait pas été provoqué (7.9%) et douze fois moins élevée que chez celles qui avaient eu recours à d'autres méthodes (49,4%). Ces résultats laissent à penser que le misoprostol est un moyen sans danger et peu coûteux pour déclencher l'avortement et qu'il entraïne moins de complications et, par conséquent, une hospitalisation de plus courte durée. On devrait considérer le misoprostol comme une option valable dans les situations où l'interruption de grossesse est légale ou indiquée pour des raisons médicales.

Resumen

La alta incidencia de abortos en Brasil y el uso creciente de misoprostol entre mujeres que tienen abortos clandestinos/peligrosos suscitó interés por determinar si había alguna asociación entre el uso de misoprostol y la incidencia de complicaciones sépticas después del aborto. A fin de someter a prueba tal asociación, se realizó un estudio retrospectivo cohorte con 1840 mujeres tratadas después de un aborto en el Instituto Materno-Infantil de Pernambuco (IMIP) entre 1988 y 1992. La incidencia de infectión (4,2%) fue inferior en las mujeres que manifestaron haber utilizado misoprostol que en aquéllas que manifestaron que el aborto no había sido inducido (7,9%) y doce veces inferior que en las mujeres que manifestaron haber utilizado otros métodos (49,4%). Estos resultados sugieren que el misoprostol es un método seguro y económico para inducir el aborto, y que origina menos complicaciones y, por consiguiente, períodos más breves de hospitalización. El misoprostol debe considerarse como una opción viable en situaciones en las que la inducción del aborto es legal o está médicamente indicada.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Alan Guttmacher Institute. Clandestine Abortion: A Latin American Reality. New York: Alan Guttmacher Institute; 1994.

    Google Scholar 

  2. HardyE, AlvesG. Factors associated with complications following induced abortion. Cadernos de Saúde Pública. 1992;8:454–8.

    Google Scholar 

  3. BarbosaR, ArilhaM. The Brazilian experience with Cytotes. Stud Fam Plann. 1993;24:236–40.

    PubMed  Google Scholar 

  4. ThongK, BairdD. Induction of abortion with mifepristone and misoprostol in early pregnancy. Br J Obstet Gynecol. 1992;99:1004–7.

    Google Scholar 

  5. BugalhoA, BiqueC, AlmeidaL, FaúndesA. The effectiveness of intravaginal misoprostol (Cytotec) in inducing abortion after eleven weeks of pregnancy. Stud Fam Plann. 1993;24:319–23.

    PubMed  Google Scholar 

  6. JainJ, MishellD. A comparison of intravaginal misoprostol with prostaglandin E2 for termination of second-trimester pregnancy. N Engl J Med. 1994;331:290–5.

    PubMed  Google Scholar 

  7. CoelhoHLL, TeixeiraAC, SantosAP, et al. Misoprostol and illegal abortion in Fortaleza, Brazil. Lancet. 1993;341:1261–3.

    PubMed  Google Scholar 

  8. CostaS, VesseyM. Misoprostol and illegal abortion in Rio de Janeiro, Brazil. Lancet. 1993;341:1258–61.

    PubMed  Google Scholar 

  9. CoelhoH, TeixeiraAC, CruzMF, et al. Misoprostol: The experience of women in Fortaleza, Brazil. Contraception. 1994;49:101–10.

    PubMed  Google Scholar 

  10. Sanchez-RamosL, KaunitzAM, DelValleGO, DelkeI, SchroederPA, BrionesDK. Labor induction with the prostaglandin E1 methyl analogue misoprostol versus oxytocin: a randomized trial. Obstet Gynecol. 1993;81:332–6.

    PubMed  Google Scholar 

  11. BugalhoA, BiqueC, MachungoF, FaúndesA. Induction of labor with intravaginal misoprostol in intrauterine fetal death. Am J Obstet Gynecol. 1994;17(2):538–41.

    Google Scholar 

  12. FletcherH, MitchellS, FrederickJ, SimeonD, BrownD. Intravaginal misoprostol versus dinoprostone as cervical ripening and labor-inducing agents. Obstet Gynecol. 1994;83:244–7.

    PubMed  Google Scholar 

  13. BugalhoA, BiqueC, MachungoF, FaúndesA. Low-dose vaginal misoprostol for induction of labor with a live fetus. Int J Gynecol Obstet. 1995;49:149–55.

    Google Scholar 

  14. BlackwellAL, ThomasPD, WarehamK, EmerySJ. Health gains from screening for infection of the lower genital tract in women attending for termination of pregnancy. Lancet. 1993;342:206–10.

    PubMed  Google Scholar 

  15. RabeT, BasseH, ThuroH, KieselDT. Action of the PGEl methyl analogue misoprostol on the human uterus in the first trimester. Geburtshilfe Frauenhielkd. 1987;47:324–31.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Faúndes, A., Santos, L.C., Carvalho, M. et al. Post-abortion complications after interruption of pregnancy with misoprostol. Adv Contracept 12, 1–9 (1996). https://doi.org/10.1007/BF01849540

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01849540

Keywords

Navigation